Evidence map›Paper›PMID 28607543›Full record

ArticleInternational journal of tryptophan research : IJTR2017

Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach.

Giuseppe Corano Scheri, Saeid Najafi Fard, Ivan Schietroma, Andrea Mastrangelo, Claudia Pinacchio, Noemi Giustini, Sara Serafino, Gabriella De Girolamo, Eugenio Nelson Cavallari, Maura Statzu and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of tryptophan research : IJTR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Probing the Interface of HIV and Inflammaging.Current HIV/AIDS reports · 2021
    Review
  8. Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases.World journal of gastrointestinal pathophysiology · 2021
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Giuseppe Corano ScheriDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Saeid Najafi FardDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Ivan SchietromaDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Andrea MastrangeloDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Claudia PinacchioDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Noemi GiustiniDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Sara SerafinoDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Gabriella De GirolamoDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Eugenio Nelson CavallariDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Maura StatzuLaboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Luca LaghiDepartment of Agro-Food Science and Technology, University of Bologna, Bologna, Italy.
Annamaria VulloDepartment of Anatomical, Histological, Forensic and Orthopaedic Sciences,Sapienza University of Rome, Rome, Italy.
Giancarlo CeccarelliDepartment of Public Health and Infectious Diseases, Azienda Policlinico Umberto I, Rome, Italy.
Vincenzo VulloDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Gabriella d'EttorreDepartment of Public Health and Infectious Diseases, Azienda Policlinico Umberto I, Rome, Italy.
Sapienza University of Rome · ITPoliclinico Umberto I · ITUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo date, no data are available regarding the effects of probiotics on the pathway of tryptophan/serotonin metabolism among human immunodeficiency virus (HIV) 1-infected individuals. Because a condition of dysbiosis might be responsible for the altered use of tryptophan described in this population, the aim of this study was to investigate the link between probiotic supplementation and serotonin levels in combined antiretroviral therapy-treated patients and the subsistence of an interplay with inflammation.

methodsWe conducted a pilot study that included 8 HIV-positive subjects. We collected blood and fecal samples before and after 6 months of probiotic supplementation, to measure the level of serotonin in serum and tryptophan in stool, the expression of CD38 and HLA-DR on peripheral CD4+ T lymphocytes (as immune activation markers), the expression of indoleamine 2,3-dioxygenase 1 messenger RNA (mRNA) and IFN-γ mRNA (as markers of tryptophan metabolism and systemic inflammation).

resultsAfter probiotic supplementation, we observed a significant increase in concentration of serum serotonin (

conclusionsConsidering that this probiotic (Vivomixx® in EU; Visbiome® in USA) has an influence on tryptophan metabolism, larger studies on this topic are needed.

Indexed as

HIVIDO-1IFN-γProbioticsserotonintryptophan

Identifiers

PMID28607543
PMCPMC5457170
OpenAlexW2619302438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.